Obstet Gynecol Sci.  2019 May;62(3):179-182. 10.5468/ogs.2019.62.3.179.

Recurrent pregnancy loss: can factor V Leiden mutations be a cause

• Reddy RR
• Mutreja D
• Moorchung
• Mukhopadhyay I

• KMID: 2445076
• DOI: http://doi.org/10.5468/ogs.2019.62.3.179

Abstract

The role of Factor V Leiden (FVL) mutation in recurrent miscarriages has been disputed. It has been hypothesized that FVL mutation in patients with recurrent miscarriages is treatable. In this study, we evaluated 78 pregnant women for FVL mutations, among whom 50 had a history of recurrent miscarriages. Only 1 (2%) of the woman was positive for heterozygous FVL mutation. The incidence of FVL mutations in patients with recurrent pregnancy loss had an odds ratio of 1.72 (95% confidence interval, 0.0681-43.8257; P>0.05). However, the findings were not statistically significant. Thus, we suggest that FVL mutation study may not be included in the battery of tests for recurrent miscarriages in the Indian population.

Keyword

Factor V Leiden; Recurrent miscarriage

MeSH Terms

Abortion, Habitual
Factor V*
Female
Humans
Incidence
Odds Ratio
Pregnancy*
Pregnant Women
Factor V

Reference

1. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008; 89:1603.

2. Hatasaka HH. Recurrent miscarriage: epidemiologic factors, definitions, and incidence. Clin Obstet Gynecol. 1994; 37:625–634.

3. The American College of Obstetricians and Gynecologists. Frequently asked questions 100, pregnancy: repeated miscarriages [Internet]. Washington, D.C.: The American College of Obstetricians and Gynecologists;c2017. cited 2017 Oct 25. Available from: https://www.acog.org/~/media/For%20Patients/faq100.pdf.

4. Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2004; 114:409–414.

5. Mariar RA, Fink LM, Miller JL. Laboratory approach to thrombotic risk. In : McPherson RA, Pincus MR, editors. Henry's clinical diagnosis and management by laboratory methods. 22nd ed. New York (NY): Elsevier;2011. p. 825.

6. Kujovich JL. Factor V Leiden thrombophilia. Genet Med. 2011; 13:1–16.

7. Mierla D, Szmal C, Neagos D, Cretu R, Stoian V, Jardan D. Association of prothrombin (A20210G) and Factor V Leiden (A506G) with recurrent pregnancy loss. Maedica (Buchar). 2012; 7:222–226.

8. Cardona H, Castañeda SA, Cardona Maya W, Alvarez L, Gómez J, Gómez JT, et al. Lack of association between recurrent pregnancy loss and inherited thrombophilia in a group of Colombian patients. Thrombosis. 2012; 2012:367823.

9. Herrmann FH, Koesling M, Schröder W, Altman R, Jimenez Bonilla R, Lopaciuk S, et al. Epidemiology of Factor V Leiden mutation in various populations: Northeastern Germany, Poland, Argentina, Venezuela, Costa Rica and India. In : Scharrer I, Schramm W, editors. 27. Hämophilie-Symposion Hamburg 1996. Berlin, Heidelberg: Springer;1998. p. 347–351. DOI: 10.1007/978-3-642-80403-8.

10. Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the factor V Arg506-->Gln mutation. Blood Coagul Fibrinolysis. 1995; 6:245–248.

11. Kumar N, Ahluwalia J, Das R, Rohilla M, Bose S, Kishan H, et al. Inherited thrombophilia profile in patients with recurrent miscarriages: experience from a tertiary care center in North India. Obstet Gynecol Sci. 2015; 58:514–517.

12. Mukhopadhyay R, Saraswathy KN, Ghosh PK. MTHFR C677T and Factor V Leiden in recurrent pregnancy loss: a study among an endogamous group in North India. Genet Test Mol Biomarkers. 2009; 13:861–865.

13. Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010; 93:1234–1243.

14. Parand A, Zolghadri J, Nezam M, Afrasiabi A, Haghpanah S, Karimi M. Inherited thrombophilia and recurrent pregnancy loss. Iran Red Crescent Med J. 2013; 15:e13708.

15. Parveen F, Shukla A, Agrawal S. Should Factor V Leiden mutation and prothrombin gene polymorphism testing be done in women with recurrent miscarriage from North India? Arch Gynecol Obstet. 2013; 287:375–381.

16. Pasquier E, Bohec C, Mottier D, Jaffuel S, Mercier B, Férec C, et al. Inherited thrombophilias and unexplained pregnancy loss: an incident case-control study. J Thromb Haemost. 2009; 7:306–311.

17. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol. 2007; 86:727–731.

18. Dilley A, Benito C, Hooper WC, Austin H, Miller C, El-Jamil M, et al. Mutations in the Factor V, prothrombin and MTHFR genes are not risk factors for recurrent fetal loss. J Matern Fetal Neonatal Med. 2002; 11:176–182.

19. Pasińska M, Soszyńska K, Runge A, Dabrowska A, Juraszek A, Janiszewska T, et al. Molecular diagnostic tests for thrombophilia in patients referred to genetic counseling clinic because due to recurrent pregnancy failure. One center's experience. Ginekol Pol. 2012; 83:178–182.

20. Vora S, Shetty S, Salvi V, Satoskar P, Ghosh K. Thrombophilia and unexplained pregnancy loss in Indian patients. Natl Med J India. 2008; 21:116–119.